Randomized phase III study comparing 5 fluorouracil (F) cyclophosphamide (C) and either theprubicin (T) or doxorubicin (A) in the treatment of advanced breast cancer (ABC), final results: How patient selection and methods of tumor assessment could influence response rate (RR)

✍ Scribed by Devaux, Y.; Lucas, N.; Mathelin, C.; Tubiana, N.; Serin, D.; Marty, P.

• Book ID: 122742875
• Publisher: Elsevier Science
• Year: 1993
• Tongue: English
• Weight: 143 KB
• Volume: 29
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/0959-8049(93)91026-H